Publication U1219 – August 2025

Andriambelosoa T, Cavailles C, Empana J-P, Mura T, Helmer C, Dauvilliers Y, Jaussent I. SCORE2-Older Persons (SCORE2-OP): Validation and Added Value of Excessive Daytime Sleepiness in a French Cohort. J Am Geriatr Soc. 2025. https://doi.org/10.1111/jgs.70047

Baggio T, Grecucci A, Crivello F, Joliot M, Tzourio C. Fronto-Parietal and Cerebellar Circuits Characterize Individuals With Higher Trait Anxiety. Eur J Neurosci. 2025;62(3):e70210. https://doi.org/10.1111/ejn.70210

Bertholet-Thomas A, De Mul A, Bernardor J, Roussey-Kesler G, Podracka L, Novo R, Nobili F, Knebelmann B, Harambat J, et al. 6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal((R))) in primary distal renal tubular acidosis. Orphanet J Rare Dis. 2025;20(1):431. https://doi.org/10.1186/s13023-025-03953-4

Bigot J, Freulon P, Hejblum BP, Leclaire A. On the potential benefits of entropic regularization for smoothing Wasserstein estimators. Electronic Journal of Statistics. 2025;19(2):3867-94. https://doi.org/10.1214/25-EJS2430

Bridge Study Group. BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]. Eye (Lond). 2025;39(12):2337-9. https://doi.org/10.1038/s41433-025-03832-z

Chakkarai S, Le Grand Q, Shaoxuan LW, Debette S, Sargurupremraj M. Unravelling the genetic architecture of cerebral small vessel disease in the context of stroke. J Cereb Blood Flow Metab. 2025:271678×251362977. https://doi.org/10.1177/0271678×251362977

Che WI, Oberg Sysojev A, Zhu C, Patasova K, InteLymph, Imacs Myogen, Smedby KE, Lundberg IE, Westerlind H, Holmqvist M. Shared genetic susceptibility between idiopathic inflammatory myopathies and common B cell lymphoma subtypes found primarily in the human leucocyte antigen region. RMD Open. 2025;11(3). https://doi.org/10.1136/rmdopen-2025-006035

Chene G, Preau M, Lenert P, Martin-Prevel Y, Giorgi R. Making the invisible visible: Data, leadership, and the future of public health. Perspect Public Health. 2025:17579139251361786. https://doi.org/10.1177/17579139251361786

Daly T. Style is the answer to the death of the academic author. Med Teach. 2025:1. https://doi.org/10.1080/0142159x.2025.2550481

Daly T. Guaranteeing girls’ right to education: an imperative for global brain health. Dement Neuropsychol. 2025;19:e20250319. https://doi.org/10.1590/1980-5764-dn-2025-0319

Daly T, Imbimbo BP. Secretase inhibition in Alzheimer’s therapeutics reveals functional roles of amyloid-beta42. Neural Regen Res. 2025. https://doi.org/10.4103/nrr.Nrr-d-24-01481

Daly T, Mastroleo I. Use of unproven interventions in clinical practice in the Declaration of Helsinki 2024: building on welcome changes. Theor Med Bioeth. 2025. https://doi.org/10.1007/s11017-025-09725-2

Daly TP, de Paiva AF. Tackling health inequalities in dementia is a public health priority. BMJ. 2025;390:r1738. https://doi.org/10.1136/bmj.r1738

Dari L, Beradid S, Constans J, Pariente A, Renoux C. Effectiveness and safety of rivaroxaban vs. apixaban in patients with atrial fibrillation and peripheral artery disease. Eur Heart J Cardiovasc Pharmacother. 2025. https://doi.org/10.1093/ehjcvp/pvaf063

de Salins V, Martinez-Tapia C, Gay P, Morel A, Bringuier M, Boudou-Rouquette P, Corsin L, Aregui A, Canovas J, Rautou P-E, Soubeyran P, Bellera C, et al. The Fibrosis-4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies. Int J Cancer. 2025. https://doi.org/10.1002/ijc.70071

Espay AJ, Ezzat K, Kepp KP, Daly T, Robakis NK, Meijer L, Imbimbo BP. Restoring amyloid-β42 and γ-secretase function in Alzheimer’s disease. Brain. 2025. https://doi.org/10.1093/brain/awaf294

Fabbri M, Del Campo N, Meissner WG, Rousseau V, Sommet A, Payoux P, […], Foubert-Samier A, Traon AP-L, Arribarat G, Peran P, Rascol O. Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study. Ann Neurol. 2025. https://doi.org/10.1002/ana.70028

Fabbri M, Harroch E, Camgrand E, Bastos PAD, Meissner WG, Llorca MC, […], Foubert-Samier A, Brefel-Courbon C. Development and Feasibility of a Mixed Virtual and in-Presence Therapeutic Education Program for Early Multiple System Atrophy Patients. Mov Disord Clin Pract. 2025. https://doi.org/10.1002/mdc3.70283

Figueiredo DM, Mu H, Osman R, Silva V, Graumans M, van Dael M, Balkhi SE, Mol H, Huss A, Vermeulen R, Hofman J, Abrantes N, Campos I, Alcon F, Contreras J, Baldi I, Bureau M, et al. Non-dietary personal pesticide exposure using silicone wristbands across 10 European countries. Environ Int. 2025;203:109734. https://doi.org/10.1016/j.envint.2025.109734

Finoco M, Ould-Slimane M, Marie-Hardy L, De Seze M, Chaleat-Valayer E, Courtois I, Bouyer B, Charles Y-P, Rannou F, Guigui P, Nguyen C, Ferrero E. Comparison of quality of life between operated and non-operated adults with painful degenerative scoliosis: a 2-year prospective multicentered observational study. Eur Spine J. 2025. https://doi.org/10.1007/s00586-025-09056-9

Haneef R, Mahrouseh N, Bessonneau P, Vandentorren S, Minier N, Chin F, Bruyere O, Devleesschauwer B, Wyper GMA. Social inequalities in COVID-19-related years of life lost in metropolitan France, 2020. Arch Public Health. 2025;83(1):215. https://doi.org/10.1186/s13690-025-01704-2

Harambat J, Guigonis V. Reflections on the Use of Mycophenolate Mofetil in Pediatric Nephrotic Syndrome. JAMA Pediatr. 2025. https://doi.org/10.1001/jamapediatrics.2025.2710

Jean FAM, Montagni I, Schwartz AN, Navarro MC, Galesne C, Macalli M, Cherruaud L, Lerouge-Bailhache M, Cote SM, Tzourio C, Galera C. Illicit substance use and attention deficit hyperactivity disorder symptoms among French university students: a multiple correspondence analysis and a cluster analysis. Eur Arch Psychiatry Clin Neurosci. 2025. https://doi.org/10.1007/s00406-025-02092-y

Joly BS, Joseph A, Bouzid R, Boisseau P, Kwon T, Dossier CD, Biebuyck N, Boyer O, Tsatsaris V, Harambat JP, et al. Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura. Blood Adv. 2025. https://doi.org/10.1182/bloodadvances.2025017638

Kone C, Kaufmann E, Richert L, editors. Bandit Pareto Set Identification in a Multi-Output Linear Model. Proceedings of Machine Learning Research; 2025.

Korobelnik J-F, Lanzetta P, Leal S, Holz FG, Clark WL, Eichenbaum D, et al. Intravitreal Aflibercept 8 mg in Neovascular Age-related Macular Degeneration: 96-Week Results from the Randomized Phase 3 PULSAR Trial. Ophthalmology. 2025. https://doi.org/10.1016/j.ophtha.2025.08.022

Le Coent Q, Legrand C, Dignam JJ, Rondeau V. Validation of a Longitudinal Marker as a Surrogate Using Mediation Analysis and Joint Modeling: Evolution of the PSA as a Surrogate of the Disease-Free Survival. Biom J. 2025;67(4):e70064. https://doi.org/10.1002/bimj.70064

Lefevre-Arbogast S, Scala P, Zorilla A, Helmer C, Chaker J, David A, Mercier F, Samieri C. Associations of plasma persistent organic pollutants with brain atrophy, cognitive decline and risk of dementia in older adults. Environ Int. 2025;203:109756. https://doi.org/10.1016/j.envint.2025.109756

Liuu E, Battisti NML, Galvin A, Compton S, Kalsi T, Paccalin M, Valero S, Soubeyran P, Welch C. Remote monitoring in older adults with cancer, opportunities and challenges: a narrative review. Aging Clin Exp Res. 2025;37(1):249. https://doi.org/10.1007/s40520-025-03161-x

Munsch G, Thibord F, Bezerra OC, Brody JA, van Hylckama Vlieg A, Gourhant L, Chen M-H, Samaria F, Germain M, Caro I, […], Debette S, Deleuze J-F, Jacqmin-Gadda H, Rodger MA, Gagnon F, Rosendaal FR, Johnson AD, Smith NL, Couturaud F, Morange P-E, Tregouet D-A. Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes. Blood. 2025. https://doi.org/10.1182/blood.2024027879

Neant N, Le MP, Bouchet S, Lagoutte-Renosi J, Gregoire M, Parant F, et al. Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study. Clin Infect Dis. 2025. https://doi.org/10.1093/cid/ciaf385

Olivier E, Hicks B, Olesen M, Fournier A, Severi G, Pottegard A, Cairat M. Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population-Based Case-Control Study. Cancer Med. 2025;14(15):e71110. https://doi.org/10.1002/cam4.71110

O.PEN-ReMIE steering committee. Rapid-sequence clinical research before and during a pandemic: Lessons learned and the way forward. Infect Dis Now. 2025;55(7):105135. https://doi.org/10.1016/j.idnow.2025.105135

Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T. Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials. NPJ Parkinsons Dis. 2025;11(1):241. https://doi.org/10.1038/s41531-025-01103-y

Palmieri L-J, Belaroussi Y, Huchet N, Fonck M, Bellera C, Brouste V, et al. Corrigendum to ‘Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohort’ [Digestive and Liver Disease 56 (2024) 1930-7]. Dig Liver Dis. 2025. https://doi.org/10.1016/j.dld.2025.07.031

Pattou M, Masanet S, Jutand M-A, Hoarau H, Sarrazin J, Pitout A, Richert L, et al . Effects of a personalized or generic three-dimensional tumoral kidney model on patient experience and caregiver-patient interactions, before and after partial nephrectomy, a randomized trial (Rein 3D Print Personalize-UroCCR 114). PLoS One. 2025;20(8):e0323515. https://doi.org/10.1371/journal.pone.0323515

Pech M, Adolphe M, Oudeyer P-Y, Sauzeon H. Broadening the lens: A review of multi-object tracking task and its use in cognitive training. Acta Psychol (Amst). 2025;258:105271. https://doi.org/10.1016/j.actpsy.2025.105271

Quiles C, de Leon J, Verdoux H. Benzodiazepines and clozapine co-prescription in clinical practice: A systematic review and expert recommendations. Expert Opin Drug Metab Toxicol. 2025. https://doi.org/10.1080/17425255.2025.2548524

Reyne B, Kamiya T, Djidjou-Demasse R, Alizon S, Sofonea MT. Leaky or polarised immunity: Non-Markovian modelling highlights the impact of immune memory assumptions. PLoS Comput Biol. 2025;21(8):e1013399. https://doi.org/10.1371/journal.pcbi.1013399

Richard S, Beurton-Aimar M, Delcourt C, Delyfer MN, editors. Superpixel-based Graph Neural Network with Hierarchical Topology for retinal image grading. 2025 International Conference on Multimedia Analysis and Pattern Recognition (MAPR); 2025 14-15 Aug. 2025.

Saint-Dizier de Almeida V, Kebir Y, Garrigou A. Training in creative focus group around intermediary object facilitation based on reflexivity. Eur J Psychol Educ. 2025;40(3):89. https://doi.org/10.1007/s10212-025-00989-9

Sloman SJ, Martinelli J, Kaski S, editors. Proxy-informed Bayesian transfer learning with unknown sources. Proceedings of Machine Learning Research; 2025.

van der Peet M, Maas P, Wegrzyn A, Lamont L, Fleming R, Bordes C, Debette S, Harms A, Hankemeier T, Kindt A. mzQuality: An Open-Source Software Tool for Quality Monitoring and Reporting of Targeted Mass Spectrometry Measurements. J Am Soc Mass Spectrom. 2025;36(8):1669-76. https://doi.org/10.1021/jasms.5c00073

Wagner E, Verdoux H, Hasan A. Clozapine and antidepressants: promising strategies, but still unanswered questions. Lancet Psychiatry. 2025;12(8):545-6. https://doi.org/10.1016/S2215-0366(25)00204-4

Xie J, Du M, Guo Y, Barboza C, Brash JT, Delmestri A, Duarte-Salles T, Gratton J, Griffier R, et al. Trends in prescription opioid use in Europe: A DARWIN EU((R)) multinational cohort study including seven European countries. Front Pharmacol. 2025;16:1608051. https://doi.org/10.3389/fphar.2025.1608051

Xuereb F, Trin K, Griffier R, Salvo F, Frasca M, Noize P, Bezin J, Pariente A. Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouse. Br J Clin Pharmacol. 2025. https://doi.org/10.1002/bcp.70199

Zaloszyc A, Harambat J. Impact of adverse childhood experiences on kidney health. Pediatr Nephrol. 2025. https://doi.org/10.1007/s00467-025-06935-7